Search clinical trials for: fibrin clot

Total 6884 results

Papworth Hospital NHS Foundation Trust
Medical Research Council; University of Oxford; University of Liverpool

Not yet recruiting

PrOtamIne doSing clOt imagiNg (POISON) Study (POISON)

Cardiac Surgery

United Kingdom
University of Giessen

Recruiting

Topical Application of PRF Before Radiation Therapy (PRF)

PRF

Germany
Vanderbilt University Medical Center

Not yet recruiting

Inpatient Monitoring of Unfractionated Heparin

Thrombosis | Blood Clot

United States
Policlinico Hospital

Recruiting

Point of Care Evaluation of Fibrinolysis in Sepsis (POCEFIS)

Sepsis | Critical Illness | Fibrinolytic Defect

Italy
Assiut University

Not yet recruiting

Impact of Antenatal Steroids on Coagulation.

Corticosteroids Adverse Reaction
Tianjin Huanhu Hospital

Recruiting

Endovascular Treatment of Acute Ischemic Stroke With Underlying Intracranial Artery Stenosis

Acute Ischemic Stroke | Large Vessel Occlusion | Intracranial Artery Occlusion With Cerebral Infarction | Endovascular Treatments

China
Hospices Civils de Lyon

Recruiting

EVALUATION OF THE OVERALL HAEMOSTATIC CAPACITY OF MIM8 WITH GLOBAL HAEMOSTASIS ASSAYS AND FIBRIN CLOT ULTRASTRUCTURE (Mim8-TGT)

Hemophilia A

France
Vilnius University
Vilnius University Hospital Santaros Klinikos

Recruiting

A Comparative Prospective Study of the Arthroscopic Meniscus Repair Methods

Meniscus Tear Caused by a Traumatic Event

Lithuania
University of Ioannina

Recruiting

Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.

Coagulation Disorder | Cardiac Surgery | CAD | Valve Heart Disease

Greece
Taichung Veterans General Hospital

Recruiting

The Effect of ACT and Tranexamic Acid on Bleeding in Cardiac Surgery

Cardiopulmonary Bypass | Heparin | Surgery, Cardiac | Tranxemic Acid | Activated Clotting Time

Taiwan
Zunyi Medical College

Recruiting

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

STEMI - ST Elevation Myocardial Infarction

China
Ondrej Hrdy

Recruiting

Evaluation of Coagulation Status of Pregnant Women in the Peripartum Period Using the Device Clotpro®

Coagulation and Hemorrhagic Disorders

Czechia
Centre Hospitalier Universitaire, Amiens

Recruiting

Interchangeability of Arterial Coagulation and Venous Coagulation, in the Context of Cardiac Surgeries Under Cardiopulmonary Bypass, Using the DMDiv Hemochron Signature Elite (COAGAV)

Hemostasis | Extracorporeal Circulation | Heparin | Cardio-pulmonary Bypass

France
University Hospital, Grenoble

Recruiting

Impact of Emicizumab on Activated Clotting Time Using the i-STAT Alinity Analyzer (EMISTAT)

Hemophilia A

France
University Hospital, Geneva

Recruiting

Bleeding of Unknown Cause: a Swiss Case-control Study (SWISS-BUC)

Bleeding Disorder

Switzerland
Inari Medical

Recruiting

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis (DEFIANCE)

Venous Thromboembolism | Deep Venous Thrombosis | Post-Thrombotic Syndrome

United States, Germany, Finland, Switzerland, United Kingdom
Penumbra Inc.

Recruiting

Comparison of Two Pulmonary Embolism Treatments

Pulmonary Embolism Acute

United States
The George Institute
Heart Research Institute

Recruiting

Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke (STARS)

Acute Ischemic Stroke

Australia
University Hospital, Clermont-Ferrand

Recruiting

Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia (GENDYSFIB)

Hereditary Dysfibrinogenemia

France
John Paul II Hospital, Krakow
Jagiellonian University; National Science Centre, Poland

Recruiting

Inflammation and Clotting Abnormalities in Aneurysmal Coronary Artery Disease (CARE-ANUERYSM)

Coronary Disease | Abdominal Aortic Aneurysm | Coronary Artery Aneurysm

Poland
Medical University of Vienna

Recruiting

Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test

Heparin-induced Thrombocytopenia

Austria
University Health Network, Toronto
Sunnybrook Health Sciences Centre; Canadian Institutes of Health Research (CIHR) and other collaborators

Recruiting

Factor In the Initial Resuscitation of Severe Trauma 2 Patients (FiiRST-2)

Coagulopathy | Traumatic Hemorrhage | Massive Hemorrhage

Canada
Duke University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)

Heart Failure | Pain | Pneumonia | Hypertension | Edema | Hemophilia | Insomnia | Pulmonary Arterial Hypertension | Coagulation Disorder | Asthma in Children | Down Syndrome | Attention Deficit Hyperactivity Disorder | Bronchopulmonary Dysplasia | Hypokalemia | Hyperphosphatemia | Primary Hyperaldosteronism | Adrenal Insufficiency and other conditions

United States, Canada
University Hospital, Brest
Bayer

Recruiting

Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease (AQUATIC)

Coronary Artery Disease

France
Bloodworks
Ergomed; Octapharma; Mary M. Gooley Hemophilia Center

Recruiting

Von Willebrand Factor in Pregnancy (VIP) Study (VIP)

Von Willebrand Diseases

United States
Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

CPP Versus PFC to Correct Coagulation Disorders in Adult Neurosurgical Patients (CLOT-CRANE)

Intracranial Hemorrhages

France
Major Extremity Trauma Research Consortium
Patient-Centered Outcomes Research Institute

Completed

PREVENTion of Clot in Orthopaedic Trauma (PREVENT CLOT)

Trauma | Blood Clot

United States, Canada
Bristol-Myers Squibb
Pfizer

Completed

Apixaban for the Acute Treatment of Venous Thromboembolism in Children

Venous Thromboembolism

United States, Spain, Canada, Austria, Germany, France, Australia, Mexico, United Kingdom, Israel, Russian Federation, Turkey, Ukraine
Pfizer

Completed

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Cancer

United States, Canada, Spain, Austria, Netherlands
Regeneron Pharmaceuticals

Active, not recruiting

A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Venous Thromboembolism

Poland, Latvia, Canada, Belgium, Bulgaria, Hungary, Lithuania
IRCCS Policlinico S. Donato

Completed

Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness (EDIPORE)

Bleeding | Surgery | Cardiac Disease | Surgical Blood Loss | Hypofibrinogenemia

Italy
Cairo University

Completed

Healing Potentiality Of Blood Clot S-PRF and A-PRF in the Treatment Of Necrotic Mature Single-Rooted Teeth With Chronic Peri-Apical Periodontitis

Necrotic Pulp

Egypt
University Hospital, Bordeaux

Completed

Targeting TFPI With Concizumab to Improve Haemostasis in Glanzmann Thrombasthenia Patients: an in Vitro Study (GLAT)

Glanzmann Thrombasthenia

France
University of Belgrade

Active, not recruiting

Impact of Advanced Platelet Rich Fibrin and Enamel Matrix Derivative on Clinical and Molecular Wound Healing Parameters After Surgical Removal of Mandibular Third Molars

Surgical Wound, Healed | Post Operative Pain

Serbia
University of Washington
National Institute of General Medical Sciences (NIGMS)

Terminated

Vitamin K Supplementation Study in Healthy Volunteers (Aim 2B)

Vitamin K Status

United States
Alliance Foundation Trials, LLC.
Patient-Centered Outcomes Research Institute

Completed

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer (CANVAS)

Cancer | Venous Thromboembolism | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Blood Clot

United States
Aristotle University Of Thessaloniki

Completed

Anticoagulation Management in Complex Cardiac Surgery

Extracorporeal Circulation

Greece
University of Texas Southwestern Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Thrombosis Outcomes in Pediatric Venous Thromboembolism (TOP)

Venous Thromboembolism

United States
University Hospital, Ghent

Completed

Coupling Between Clotting Characteristics in Chronic Hemodialysis Patients and the Hemodialyzer Patency (ClotPara)

Bleeding | Coagulation

Belgium
Sanofi

Active, not recruiting

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Venous Thromboembolism

United States
Sanofi

Active, not recruiting

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Venous Thromboembolism

United States
Novo Nordisk A/S

Completed

A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.

Healthy Volunteers

Netherlands
Rajaie Cardiovascular Medical and Research Center
Tehran Heart Center

Completed

Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI (REWARF-STEMI)

ST Segment Elevation Myocardial Infarction | Left Ventricular Thrombus

Iran, Islamic Republic of
Mayo Clinic

Completed

The Randomized OPTIMAL-ACT Trial

Coronary Artery Disease | Ischemic Heart Disease | Anticoagulant-induced Bleeding | Coronary Syndrome

United States
IRCCS Policlinico S. Donato

Completed

Hemostatic Profile of Post COVID-19/Long COVID-19 Patients (LCV)

COVID-19 | Post-acute COVID-19 Syndrome

Italy
Medical College of Wisconsin

Terminated

Coagulation and Fibrinolysis of Estradiol in Transwomen

Transgenderism | Clotting Disorder

United States
Wake Forest University Health Sciences

Terminated

Clot Dissolving Treatment for Blood Clots in the Lungs

Pulmonary Embolism

United States
University of Liverpool
University of Leeds; Liverpool John Moores University; Liverpool Heart and Chest... and other collaborators

Terminated

The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function (RALiC)

Atrial Fibrillation | Chronic Kidney Disease

United Kingdom
Daiichi Sankyo, Inc.

Completed

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Cardiac Disease

United States, Spain, Canada, Lebanon, Turkey, Austria, Croatia, Egypt, France, Hungary, India, Israel, Ukraine, United Kingdom
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Completed

DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval

Ischemic Stroke

Australia, Singapore, China, Vietnam

Search clinical trials for: fibrin clot

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations